Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients.

Lung cancer (Amsterdam, Netherlands) - 1 Mar 2021

Zhou Fei, Huang Yan, Cai Weijing, Li Jin, Su Chunxia, Ren Shengxiang, Wu Chunyan, Zhou Caicun

Abstract excerpt

PURPOSE: The distribution of genetic mutations differs between pure pulmonary sarcomatoid carcinoma (PSC) and biphasic PSC; however, most of the enrolled cases in previous studies are biphasic PSC. The current study aimed to investigate the genomic and immunologic profiles of pure PSC in the Chinese population. MATERIALS AND METHODS: Next-generation sequencing analysis of a panel of 1021 genes was performed on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Genomics

Share to Lung Neoplasms

Share to Microsatellite Instability

Share to Nuclear Proteins

Source

Identifiers

PMID: 33454519
DOI: 10.1016/j.lungcan.2021.01.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients.PMID 33454519Read ↗

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profilesSemantic proximity Read ↗

Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinomaSemantic proximity Read ↗

Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSemantic proximity Read ↗

Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53.Semantic proximity Read ↗

Comprehensive molecular profiling of pulmonary pleomorphic carcinomaSemantic proximity Read ↗

Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.Semantic proximity Read ↗

Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies.Semantic proximity Read ↗

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.Semantic proximity Read ↗

Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.